Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic lymphocytic leukemia.

T J Kipps1

  • 1Department of Medicine, University of California, San Diego, La Jolla 92093-0663, USA.

Current Opinion in Hematology
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Research into chronic lymphocytic leukemia (CLL) is advancing, though a cure remains elusive. New insights into CLL genetics and biology aid patient stratification and treatment strategies, with novel therapies in clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.

Leukemia·2017
Same author

Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.

Leukemia·2017
Same author

Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.

Leukemia·2017
Same author

Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.

Leukemia·2017
Same author

Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib.

Leukemia·2016
Same author

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Leukemia·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Chronic lymphocytic leukemia (CLL) remains a significant focus of research.
  • Despite progress, a definitive cure for CLL is not yet established.

Purpose of the Study:

  • To review recent advances in understanding CLL genetics, biology, and staging.
  • To explore how this knowledge can improve patient stratification and treatment selection.
  • To highlight emerging therapeutic strategies for CLL.

Main Methods:

  • Review of current literature on CLL genetics and biology.
  • Analysis of clinical staging advancements.
  • Overview of ongoing clinical trials for novel CLL therapies.

Main Results:

Related Experiment Videos

  • Significant progress in understanding the genetic and biological underpinnings of CLL.
  • Improved ability to classify CLL subtypes based on cytogenesis and progression.
  • Identification of several promising novel treatment modalities.

Conclusions:

  • Enhanced understanding of CLL facilitates personalized treatment approaches.
  • Novel therapies including targeted drugs, antibodies, stem cell, and gene therapy show promise.
  • Continued research is crucial for developing a cure for CLL.